全文获取类型
收费全文 | 1884篇 |
免费 | 131篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 18篇 |
妇产科学 | 51篇 |
基础医学 | 287篇 |
口腔科学 | 27篇 |
临床医学 | 164篇 |
内科学 | 431篇 |
皮肤病学 | 35篇 |
神经病学 | 261篇 |
特种医学 | 50篇 |
外科学 | 186篇 |
综合类 | 12篇 |
一般理论 | 1篇 |
预防医学 | 204篇 |
眼科学 | 20篇 |
药学 | 76篇 |
中国医学 | 2篇 |
肿瘤学 | 183篇 |
出版年
2023年 | 15篇 |
2022年 | 17篇 |
2021年 | 35篇 |
2020年 | 24篇 |
2019年 | 27篇 |
2018年 | 48篇 |
2017年 | 36篇 |
2016年 | 39篇 |
2015年 | 39篇 |
2014年 | 43篇 |
2013年 | 67篇 |
2012年 | 106篇 |
2011年 | 117篇 |
2010年 | 73篇 |
2009年 | 58篇 |
2008年 | 105篇 |
2007年 | 95篇 |
2006年 | 112篇 |
2005年 | 88篇 |
2004年 | 80篇 |
2003年 | 60篇 |
2002年 | 61篇 |
2001年 | 61篇 |
2000年 | 54篇 |
1999年 | 65篇 |
1998年 | 20篇 |
1997年 | 18篇 |
1996年 | 16篇 |
1995年 | 14篇 |
1994年 | 16篇 |
1993年 | 11篇 |
1992年 | 42篇 |
1991年 | 29篇 |
1990年 | 44篇 |
1989年 | 24篇 |
1988年 | 34篇 |
1987年 | 16篇 |
1986年 | 15篇 |
1985年 | 19篇 |
1984年 | 13篇 |
1983年 | 10篇 |
1981年 | 9篇 |
1979年 | 13篇 |
1976年 | 11篇 |
1973年 | 11篇 |
1972年 | 8篇 |
1971年 | 13篇 |
1970年 | 8篇 |
1968年 | 7篇 |
1966年 | 10篇 |
排序方式: 共有2018条查询结果,搜索用时 15 毫秒
101.
102.
Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer 下载免费PDF全文
Benoy IH Salgado R Elst H Van Dam P Weyler J Van Marck E Scharpé S Vermeulen PB Dirix LY 《Breast cancer research : BCR》2005,7(2):R210-R219
103.
de Jonge ME Huitema AD van Dam SM Rodenhuis S Beijnen JH 《Therapeutic drug monitoring》2005,27(6):756-765
The anticancer prodrug cyclophosphamide (CP) is activated by the formation of 4-hydroxycyclophosphamide (4OHCP), which decomposes into phosphoramide mustard (PM). This activation pathway is inhibited by thiotepa. CP is inactivated by formation of 2-dechloroethylcyclophosphamide (2DCECP). The aim of this study was to develop a population pharmacokinetic model describing the complex pharmacokinetics of CP, 4OHCP, 2DCECP, and PM when CP is administered in a high-dose combination with thiotepa and carboplatin. Patients received a combination of CP (1000-1500 mg/m/d), carboplatin (265-400 mg/m/d), and thiotepa (80-120 mg/m/d) administered in short infusions over 4 days. Twenty blood samples were collected per patient per course. Concentrations of CP, 4OHCP, 2DCECP, PM, thiotepa, and tepa were determined in plasma. Using NONMEM, an integrated population pharmacokinetic model was used to describe the pharmacokinetics of CP, 4OHCP, 2DCECP, and PM, including the already described processes of autoinduction of CP and the interaction with thiotepa. Data were available on 35 patients (70 courses). The pharmacokinetics of CP were described with a 2-compartment model, and those of 4OHCP, 2DCECP, and PM with 1-compartment models. Before onset of autoinduction, it was assumed that CP is eliminated through a noninducible pathway accounting for 20% of total CP clearance, whereas 2 inducible pathways resulted in formation of 4OHCP (75%) and 2DCECP (5%). It was assumed that 4OHCP was fully converted to PM. Induction of CP metabolism was mediated by 2 hypothetical amounts of enzyme whose quantities increased in time in the presence of CP (kenz=0.0223 and 0.0198 hours). Induction resulted in an increased formation of 4OHCP (approximately 50%), PM (approximately 50%), and 2DCECP (approximately 35%) during the 4-day course, and concomitant decreased exposure to CP (approximately 50%). The formation of 2DCECP was not inhibited by thiotepa. Apparent volumes of distribution of CP, PM, and 2DCECP could be estimated being 43.7, 55.5, and 18.5 L, respectively. Exposure to metabolites varied up to 9-fold. The complex population pharmacokinetics of CP, 4OHCP, 2DCECP, and PM in combination with thiotepa and carboplatin has been established and may form the basis for further treatment optimization with this combination. 相似文献
104.
105.
106.
Maier O van der Heide T van Dam AM Baron W de Vries H Hoekstra D 《Molecular and cellular neurosciences》2005,28(2):390-401
Remyelination, as potential treatment for demyelinating diseases like multiple sclerosis (MS), requires the formation of new axoglial interactions by differentiating oligodendrocyte progenitor cells. Since the oligodendrocyte-specific isoform of neurofascin, NF155 (neurofascin isoform of 155 kDa), may be important for establishing axoglial interactions, we analyzed whether its expression is changed in chronic relapsing experimental allergic encephalomyelinitis (EAE). Although overall expression of NF155 was not changed, immunoreactivity of NF155 was dramatically increased in EAE lesion sites indicating an enhanced accessibility of NF155 epitopes. As this may be due to infiltrating plasma components, for example, fibronectin, we analyzed whether fibronectin affects the intracellular distribution and membrane association of NF155 in primary oligodendrocytes. In oligodendrocytes cultivated on polylysine, NF155 was recruited to membrane microdomains (rafts) during development and became enriched in secondary and tertiary processes. Fibronectin perturbed localization and raft association of NF155 and inhibited the morphological differentiation of oligodendrocytes. Consistent with the in vitro data, raft association of NF155 was reduced in spinal cord of EAE rats. The results suggest that the association of NF155 to microdomains in the oligodendrocyte membrane is required for its participation in intermolecular interactions, which are important for myelination and/or myelin integrity. 相似文献
107.
Inflammation in the central nervous system is an early hallmark of many neurodegenerative diseases including Alzheimer's disease (AD). Recently, increasing evidence suggests that hypercholesterolemia during midlife and abnormalities in the cholesterol metabolism could have an important role in the pathogenesis of AD. In the present study, we have evaluated the effect of high cholesterol (HC) diet on the expression of interleukin-6 (IL-6), a cytokine involved in neurodegeneration, and caspase-1, that is responsible for the cleavage of the precursors of interleukin-1 beta (IL-1 beta) and interleukin-18 (IL-18) in the brain of apolipoprotein E (Apo E) knock-out (KO) and wild type (WT) mice. The density of IL-6-positive cells was increased in the hippocampus (p<0.0001) and the dorsal part of the cortex (p<0.001) of KO and WT mice on HC diet (KOHC and WTHC mice, respectively) compared to KO and WT mice on ND (KOND and WTND mice, respectively). KOHC mice had increased caspase-1 positive cells and staining intensity in the hippocampus in comparison with WTHC mice (p<0.01). In the hippocampus, the density of caspase-1 positive cells was also higher in KOHC compared to KOND mice (p<0.05) and KOHC compared with WTHC mice (p<0.01). There was a major increase in caspase-1 immunoreactivity and cell density in both the dosal part of the cortex (p<0.001) and the lateral part of the cortex (p<0.005) in KO and WT mice on HC diet compared to ND. The findings of the present study indicate that chronic exposure to HC diet increases the expression of the two important inflammatory mediators IL-6 and caspase-1 in the brain of KO and WT mice. In the case of caspase-1, we report a major difference in the effect of HC diet on the KO mice compared to WT mice in the hippocampus. Increased expression of inflammatory mediators involved in neurodegeneration could be a potential mechanism by which hypercholesterolemia and HC diet increase the risk of AD. 相似文献
108.
109.
110.
Bouma AW van Dam B Meynaar IA Peltenburg HG Walenbergh-van Veen MC 《Nederlands tijdschrift voor geneeskunde》2004,148(33):1642-1645
A 44-year-old female was found comatose after attempting suicide. Toxicological screening showed phenobarbital intoxication. The patient was treated symptomatically. After ten days her serum level of phenobarbital still had not decreased and she was not clinically recovered. The patient was transferred to another hospital for hemoperfusion to decrease the level of phenobarbital. After hemoperfusion the level of phenobarbital dropped significantly and the patient recovered neurologically. Phenobarbital has a long elimination half-life and for this reason it is advisable to use means to accelerate clearance until the clinical condition of the patient shows improvement. Multiple-dose activated charcoal effects the elimination of phenobarbital. If elimination needs to be speeded up, then hemoperfusion can be considered. If this technique is unavailable, hemodialysis is a good alternative. 相似文献